Winner 2013 Webby Awards for Best Political Website
Top Banner, Site wide
Apr 18, 2014

 Choose a size
Text Size

Top Leaderboard, Site wide

Star-Spangled Baggage
Science Finds New Routes to Energy




The Divide


Truthdig Bazaar
Creation

Creation

By Gore Vidal
$17.95

more items

 
Ear to the Ground

Study: Herpes Drug Can Slow HIV Progression

Email this item Email    Print this item Print    Share this item... Share

Posted on Feb 15, 2010
aciclovir
Wikimedia Commons / Ragesoss

Tablets of the antiviral drug aciclovir.

A study published in The Lancet has found that aciclovir, a drug frequently used to treat genital herpes, could “help people with HIV infection stay healthy for longer,” according to Dr. Jairam Lingappa, leader of the research team out of the University of Washington in Seattle.  —KA

BBC:

Gus Cairns, editor of HIV Treatment Update, said: “It’s nice to see a positive result in this field.

“There are biological reasons to believe that treating people’s herpes could make them less likely to acquire HIV, or less likely to transmit it if they already have it, but results of trials testing the idea have been disappointing.

“Now at least we find that aciclovir, a very cheap, non-toxic and widely-available drug, can prolong the time some patients may be able to stay off the more expensive, and sometimes toxic, HIV drugs.”

He added that the delay in HIV progression seen in the study may translate into a year or two off HIV medications.

Read more

More Below the Ad

Advertisement

Square, Site wide

New and Improved Comments

If you have trouble leaving a comment, review this help page. Still having problems? Let us know. If you find yourself moderated, take a moment to review our comment policy.

Newsletter

sign up to get updates


 
 
Right 1, Site wide - BlogAds Premium
 
Right 2, Site wide - Blogads
 
Join the Liberal Blog Advertising Network
 
 
 
Right Skyscraper, Site Wide
 
Join the Liberal Blog Advertising Network
 

A Progressive Journal of News and Opinion   Publisher, Zuade Kaufman   Editor, Robert Scheer
© 2014 Truthdig, LLC. All rights reserved.